New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
November 17, 2023 - Teva announced the FDA approval of an AB-rated generic version of Eli Lilly’s Forteo (teriparatide) subcutaneous injection.
Download PDF
Return to publications
